MIP PHARMA DANMARK ApS: Financial statements 2023
CVR: 32886280
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -38,668 and a net result of DKK -65,052 compared with DKK -79,066 the year before. Equity in the 2023 report amounted to DKK -451,903.
- Gross Profit
- DKK -38,668
- Profit/Loss
- DKK -65,052
- Equity
- DKK -451,903
- Total Assets
- DKK 21,637
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -39 t. | -65 t. | -452 t. | - |
| 2022 | - | -48 t. | -79 t. | -387 t. | - |
| 2021 | - | -39 t. | -53 t. | -308 t. | - |
| 2020 | - | -24 t. | -38 t. | -255 t. | 0 |
| 2019 | - | -23 t. | -33 t. | -217 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.